Century Therapeutics IPSC
NASDAQ IPSC
$1.53 -0.08 (-4.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Asset Writedowns and Impairment (2023 - 2025)

Updated

Century Therapeutics (IPSC) posted Asset Writedowns and Impairment of $6.76 million for FY2025, up 56.3% from $4.33 million in FY2024.

Analysis

Century Therapeutics (IPSC) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

  • Business Quant data shows IPSC's Asset Writedowns and Impairment at $4.33 million in FY2024 (-73.6%) and $16.37 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Century Therapeutics 290.68 Mn -213.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 6.76 Mn
Dec 31, 2024 4.33 Mn
Dec 31, 2023 12.15 Mn
Jun 30, 2023 4.22 Mn
API Access

Century Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IPSC&period=max&api_key=YOUR_API_KEY